| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f664356294234e6c9aed711394a36e40 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
1986-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395483301ddef17652f0d05496fa4f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee2c6aa8b784420debab7c4ff0ea898c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_891a1782aa8002d73decb16b0b4c2eff |
| publicationDate |
1991-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5077389-A |
| titleOfInvention |
Chemical product usable as a non-radioactive carrier |
| abstract |
The present invention relates to a chemical product usable as a non-radioactive carrier which comprises (1) a unit of a polyformyl compound having at least three formyl groups per molecule, (2) at least two units of an amino group-containing chelating compound bonded to the polyformyl compound by a methyleneimine linkage (--CH═N--) or a methyleneamine linkage (--CH 2 NH--) between a formyl group in the polyformy compound and an amino group in the chelating compound, optionally followed by reduction, (3) at least one unit of an amino group-containing physiologically active substance bonded to the polyformyl compound by a methyleneimine linkage or a methyleneamine linkage between a formyl group in the polyformyl compound and the amino group in the physiologically active substance, optionally followed by reduction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007274945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8454934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7288253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2019693-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5863518-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2019693-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006062783-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7318925-B2 |
| priorityDate |
1982-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |